AMGN vs BAX
By Alex · Tickerpine
Amgen Inc. vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | BAX |
|---|---|---|
| Price | $416.18 | $26.95 |
| Market cap | $225.15B | $13.93B |
| P/E ratio | 25.7 | — |
| ROE | 91.47% | -14.37% |
| Profit margin | 22.95% | -9.27% |
| Revenue growth | 9.50% | 5.30% |
| Dividend yield | 2.43% | 0.14% |
| Beta | 0.41 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs BAX in plain English
- AMGN is the bigger company — about 16.2× the market cap of BAX.
- AMGN earns a higher return on equity (91% vs -14%).
- AMGN is growing revenue faster (10% vs 5%).
- AMGN has the higher dividend yield (2.43% vs 0.14%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.